Showing results (2671-2680 of 11,043) with videos related to
Sort By:
Pageof 1,105
Journal of the National Cancer Institute|April 4, 2024
Targeting fusion oncoproteins in childhood cancers: challenges and future opportunities for developing therapeuticsSharad K Verma, Keren L Witkin, Anu Sharman, et al.Journal of the National Cancer Institute|April 4, 2024
Alcohol and colorectal cancer risk, subclassified by mutational signatures of DNA mismatch repair deficiencyAiping Fang, Tomotaka Ugai, Carino Gurjao, et al.Journal of the National Cancer Institute|October 3, 2024
Implications of the initial Braidwood v. Becerra ruling for colorectal cancer outcomes: a modeling studyRosita Van Den Puttelaar, Kewei Sylvia Shi, Robert Smith, et al.Journal of the National Cancer Institute|September 30, 2024
Automated patient selection and care coaches to increase advance care planning for patients with cancerMichael F Gensheimer, Winifred Teuteberg, Manali I Patel, et al.Journal of the National Cancer Institute|October 1, 2024
When is prostate cancer really cancer?Matthew R Cooperberg, Avery E Braun, Alejandro Berlin, et al.Journal of the National Cancer Institute|September 16, 2024
County-level jail and state-level prison incarceration and cancer mortality in the United StatesJingxuan Zhao, Sandhya Kajeepeta, Christopher R Manz, et al.Journal of the National Cancer Institute|September 23, 2024
Tracking community outreach and engagement activities among National Cancer Institute-designated cancer centersTodd Burus, Caree R McAfee, Pamela C Hull, et al.Journal of the National Cancer Institute|September 23, 2024
Utility of genomic testing in children, adolescents, and young adults with cancerEmily Debortoli, Ella McGahan, Tatiane Yanes, et al.Journal of the National Cancer Institute|March 1, 2024
Assessing racial, ethnic, and nativity disparities in US cancer mortality using a new integrated platformMandi Yu, Lihua Liu, James Todd Gibson, et al.Journal of the National Cancer Institute|March 8, 2024
Spatial intratumor heterogeneity of programmed death-ligand 1 expression predicts poor prognosis in resected non-small cell lung cancerYusuke Nagasaki, Tetsuro Taki, Kotaro Nomura, et al.Pageof 1,105